How China's Patent Linkage System Will be Implemented

Ting Wu of Haiwen & Partners raises some questions to highlight how China's newly implemented drug patent linkage system attempts to resolve drug patent disputes in the early stages, which will have a sweeping impact on market entry strategies for chemical drugs in China

9 minute readAugust 13, 2021 at 03:00 AM
By
Susan Mok
How China's Patent Linkage System Will be Implemented

Summary


  • The patent linkage system intends to resolve drug patent disputes between originators and generic drug applicants in the early stages
  • The Chinese drug patent linkage system does not apply

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

  • ✓ A database of 3000+ essential documents, including key PRC laws translated into English
  • ✓ Newsletters with business-critical and sector-specific updates
  • ✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)